Report Code : CVMI2603252601528 | Published Date : March 30, 2025

1 | Market Overview

The global arbovirus testing market is rapidly expanding due to the increasing prevalence of arboviral infections such as dengue, Zika, chikungunya, West Nile virus, and yellow fever. These viruses, transmitted through arthropods like mosquitoes and ticks, pose serious public health threats, especially in tropical and subtropical regions. Arbovirus diagnostics are essential for surveillance, outbreak control, differential diagnosis, and monitoring of vaccine efficacy. Demand is driven by vector migration induced by global warming, urbanization, rising international travel, and recurrent outbreaks. Technologies in this market range from molecular (RT-PCR, LAMP) and serological (ELISA, immunofluorescence) tests to next-generation sequencing (NGS) and rapid point-of-care devices.

 

2 | Market Size and Forecast

Year

Market Value (USD billion)

Notes

2019

1.06

Baseline value from regional outbreak response data

2024

1.84

CAGR (2019–2024): 11.6%

2031

4.67

CAGR (2024–2031): 14.2%

The forecast reflects increasing integration of decentralized testing, expanded vector surveillance programs, and public health investment, particularly in Asia-Pacific and Latin America.

 

3 | Primary Market Drivers

  • Growing disease burden: Arboviruses affect over 400 million people annually, straining healthcare systems during peak outbreak periods.
  • Climate change and vector expansion: Rising temperatures and urban water accumulation increase vector habitats, pushing arboviruses into new geographies.
  • Government and NGO surveillance programs: WHO, PAHO, and CDC invest in large-scale testing infrastructure to support real-time epidemic intelligence.
  • Travel and globalization: Cross-border infection risk requires faster, scalable diagnostic solutions.
  • Advancements in multiplex and portable diagnostics: New platforms detect multiple arboviruses simultaneously at the point of care.

 

4 | Market Challenges

  • Limited laboratory capacity in rural regions: Inadequate access to trained personnel and PCR infrastructure hinders early detection.
  • Cross-reactivity in serological tests: Antibody-based assays can misidentify dengue, Zika, and yellow fever due to structural similarity.
  • High cost of molecular diagnostics: PCR-based tests remain unaffordable in some low-income settings.
  • Regulatory fragmentation: Lack of harmonized guidelines delays cross-border kit approvals.
  • Intermittent demand outside outbreak periods: Manufacturers face fluctuating demand cycles based on seasonal and regional outbreaks.

 

5 | Competitive Landscape

Company

Est. 2024 Share

Strengths

Recent Strategic Move

Abbott Laboratories

14%

Point-of-care rapid tests, strong public-sector partnerships

Deployed dual dengue-Zika rapid test across Southeast Asia

Roche Diagnostics

12%

High-throughput RT-PCR, automation

Added arbovirus panels to cobas® Liat system for outbreak response

Thermo Fisher Scientific

11%

Reagents and molecular testing platforms

Partnered with Caribbean labs to deploy mobile PCR stations

Bio-Rad Laboratories

9%

Multiplex ELISA kits, vector surveillance tools

Launched new IgM panel for flavivirus differentiation

Qiagen

8%

RNA extraction and sample prep kits

Introduced scalable vector monitoring workflow with qPCR integration
         

 

6 | Detailed Market Segmentation

By Technology

  • RT-PCR and qPCR Assays: 38%
  • ELISA and Immunoassays: XX%
  • Rapid Diagnostic Tests (RDTs): XX%
  • Loop-Mediated Isothermal Amplification (LAMP): XX%
  • Next-Generation Sequencing (NGS): XX%

 

By Virus Type

  • Dengue Virus: 41%
  • Zika Virus
  • Chikungunya Virus
  • West Nile Virus
  • Yellow Fever Virus
  • Others (e.g., Japanese Encephalitis, Mayaro, Rift Valley Fever)

 

By End User

  • Public Health Laboratories
  • Hospitals and Clinics
  • Research Institutes
  • Diagnostic Centers

 

By Region

  • Asia-Pacific – 39% (highest burden and surveillance expansion)
  • Latin America – XX%
  • Africa – XX%
  • North America & Europe – Focus on imported case detection and vector monitoring

 

7 | Technology and Innovation

  • AI-integrated outbreak tracking systems linking diagnostic data to geographic vector mapping.
  • Multiplex PCR kits with internal controls for simultaneous detection of 4+ arboviruses.
  • Portable isothermal amplification (LAMP) devices with solar-powered batteries for field diagnostics.
  • Next-gen serological assays that distinguish closely related flaviviruses through epitope-level specificity.
  • Self-contained microfluidic cartridges enabling rapid testing in remote settings without lab infrastructure.

 

8 | Regulatory Environment

  • WHO Prequalification (PQDx): Enables bulk procurement by UN agencies.
  • FDA Emergency Use Authorizations (EUAs): Granted during epidemic surges (e.g., Zika 2015–2016).
  • CE Mark adoption in Europe facilitating quicker regional approvals.
  • Latin American harmonization efforts under PAHO for regional rapid test approvals.

 

9 | Strategic Outlook

  • Manufacturers should focus on multiplex and climate-resilient diagnostic kits.
  • Governments must invest in mobile lab units and regional training programs.
  • Private labs and CROs can offer vector-borne panels as part of travel-related testing.
  • Academic partnerships will accelerate development of universal arbovirus biomarker panels.
  • Regional warehousing and tiered pricing models will improve outbreak preparedness.




Reasons To Buy

Image



Scope

Image

Key Players

  • Abbott
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • PerkinElmer
  • Randox Laboratories
  • Creative Diagnostics
  • Merck KGaA

 

Global Arbovirus Testing Market Report

  1. 1. Global Arbovirus Testing Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Arbovirus Testing Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Arbovirus Testing Market Research Report - Preface
    1. 2.1 Global Arbovirus Testing Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Test Type
      2. 2.1.2 By Virus Type
      3. 2.1.3 By End-User
      4. 2.1.4 By Region
    3. Global Arbovirus Testing Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Test Type, By Virus Type, By End-User, By Country
    3. 3.3. Opportunities – By Test Type, By Virus Type, By End-User, By Country
    4. 3.4. Trends – By Test Type, By Virus Type, By End-User, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Arbovirus Testing Market Research Report – DROTs Impact Analysis
    4. Global Arbovirus Testing Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Arbovirus Testing Market, By Test Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 ELISA
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 RT-PCR
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Immunoassay
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 5.4 Others
      1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Arbovirus Testing Market, By Virus Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Dengue
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Zika
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Chikungunya
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 6.4 Yellow Fever
      1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 6.5 West Nile Virus
      1. 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.6 Others
      1. 6.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Arbovirus Testing Market, By End-User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Hospitals
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Diagnostic Laboratories
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Research Institutes
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 7.4 Public Health Agencies
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Arbovirus Testing Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 8.5 Middle East & Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 8.6 Global Arbovirus Testing Market - Opportunity Analysis Index, By Test Type, By Virus Type, By End-User, and Region, 2024 - 2031
    9. North America Global Arbovirus Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 ELISA
      2. 9.1.2 RT-PCR
      3. 9.1.3 Immunoassay
      4. 9.1.4 Others
      9.2 By Virus Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Dengue
      2. 9.2.2 Zika
      3. 9.2.3 Chikungunya
      4. 9.2.4 Yellow Fever
      5. 9.2.5 West Nile Virus
      6. 9.2.6 Others
      9.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Hospitals
      2. 9.3.2 Diagnostic Laboratories
      3. 9.3.3 Research Institutes
      4. 9.3.4 Public Health Agencies
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
      9.5 North America Global Arbovirus Testing Market – Opportunity Analysis Index, By Test Type, By Virus Type, By End-User, and Country, 2024 - 2031
      9.6 Regional Trends Analysis
      9.7 North America Global Arbovirus Testing Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Global Arbovirus Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 ELISA
      2. 10.1.2 RT-PCR
      3. 10.1.3 Immunoassay
      4. 10.1.4 Others
      10.2 By Virus Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Dengue
      2. 10.2.2 Zika
      3. 10.2.3 Chikungunya
      4. 10.2.4 Yellow Fever
      5. 10.2.5 West Nile Virus
      6. 10.2.6 Others
      10.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Hospitals
      2. 10.3.2 Diagnostic Laboratories
      3. 10.3.3 Research Institutes
      4. 10.3.4 Public Health Agencies
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Netherlands
      8. 10.4.8 Poland
      9. 10.4.9 Rest of Europe
      10.5 Europe Global Arbovirus Testing Market – Opportunity Analysis Index, By Test Type, By Virus Type, By End-User, and Country, 2024 - 2031
      10.6 Regional Trends Analysis
      10.7 Europe Global Arbovirus Testing Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Global Arbovirus Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 ELISA
      2. 11.1.2 RT-PCR
      3. 11.1.3 Immunoassay
      4. 11.1.4 Others
      11.2 By Virus Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Dengue
      2. 11.2.2 Zika
      3. 11.2.3 Chikungunya
      4. 11.2.4 Yellow Fever
      5. 11.2.5 West Nile Virus
      6. 11.2.6 Others
      11.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Hospitals
      2. 11.3.2 Diagnostic Laboratories
      3. 11.3.3 Research Institutes
      4. 11.3.4 Public Health Agencies
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & NZ
      6. 11.4.6 ASEAN
      7. 11.4.7 Rest of Asia-Pacific
      11.5 Asia-Pacific Global Arbovirus Testing Market – Opportunity Analysis Index, By Test Type, By Virus Type, By End-User, and Country, 2024 - 2031
      11.6 Regional Trends Analysis
      11.7 Asia-Pacific Global Arbovirus Testing Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Global Arbovirus Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 ELISA
      2. 12.1.2 RT-PCR
      3. 12.1.3 Immunoassay
      4. 12.1.4 Others
      12.2 By Virus Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Dengue
      2. 12.2.2 Zika
      3. 12.2.3 Chikungunya
      4. 12.2.4 Yellow Fever
      5. 12.2.5 West Nile Virus
      6. 12.2.6 Others
      12.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Hospitals
      2. 12.3.2 Diagnostic Laboratories
      3. 12.3.3 Research Institutes
      4. 12.3.4 Public Health Agencies
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
      12.5 Latin America Global Arbovirus Testing Market – Opportunity Analysis Index, By Test Type, By Virus Type, By End-User, and Country, 2024 - 2031
      12.6 Regional Trends Analysis
      12.7 Latin America Global Arbovirus Testing Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East & Africa Global Arbovirus Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 ELISA
      2. 13.1.2 RT-PCR
      3. 13.1.3 Immunoassay
      4. 13.1.4 Others
      13.2 By Virus Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Dengue
      2. 13.2.2 Zika
      3. 13.2.3 Chikungunya
      4. 13.2.4 Yellow Fever
      5. 13.2.5 West Nile Virus
      6. 13.2.6 Others
      13.3 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Hospitals
      2. 13.3.2 Diagnostic Laboratories
      3. 13.3.3 Research Institutes
      4. 13.3.4 Public Health Agencies
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 South Africa
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
      13.5 Middle East & Africa Global Arbovirus Testing Market – Opportunity Analysis Index, By Test Type, By Virus Type, By End-User, and Country, 2024 - 2031
      13.6 Regional Trends Analysis
      13.7 Middle East & Africa Global Arbovirus Testing Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
      14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Abbott
      2. 14.2.2 Thermo Fisher Scientific
      3. 14.2.3 Bio-Rad Laboratories
      4. 14.2.4 PerkinElmer
      5. 14.2.5 Randox Laboratories
      6. 14.2.6 Creative Diagnostics
      7. 14.2.7 Merck KGaA
    15. Data Collection Method and Research Approach
    16. Principal Presumptions and Acronyms




    2.  
  2.